Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Seattle Genetics licenses monoclonal antibodies from Mabtech

March 18, 2002

Ricerca to produce CEP-7055 for Cephalon

March 18, 2002

Trisenox approved in Europe for acute promyelocytic leukemia

March 15, 2002

Antitumor activity of AN-238 against human colorectal cancers independent of p53 status

March 15, 2002

Signal discloses a novel group of JNK inhibitors for a wide range of conditions

March 15, 2002

SLIL claims potential new treatments for prostate cancer

March 14, 2002

Derivatives with antitumor activity identified at Zentaris

March 14, 2002

FDA issues complete review letter for Bexxar, requests further clinical studies

March 14, 2002

Genmab and Bionomics collaborate on human antibody development for angiogenesis targets

March 14, 2002

Ricerca inlicenses RAP-3 gene for oncology drug discovery

March 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...